There were 1,123 press releases posted in the last 24 hours and 432,328 in the last 365 days.

Contact

Please use this form to send email to PR contact of this press release:
Parvus Therapeutics Announces Exclusive Worldwide License and Collaboration Agreement for the Development and Commercialization of Its Lead Nanomedicine to Treat Type 1 Diabetes

TO:



FROM:

Please check your email address!

Please, do not fill this field.

Please, do not change this field.

Please, do not fill if your javascript is turned off.

captcha image